uraa-quartely.blogspot.com
That collaboration is expected to land more research dollarwsfor , one of four researc h centers. The board of regents votef June 19 to breakup UMBI’s centerw and parcel them off to various USM The 25-year-old biotech research institutde was criticized for not landing enough research dollars or turnintg its research into commercially viable enterprises. Researcheres at the Center forMarines Biotechnology, UMB, the University of Baltimore County and the will join forces to creatr a new research center, as a result of the UMBI Staff at UMB’s stem cell research center, headed by laudee scientist Dr. Curt Civin, will be part of that USM ChancellorWilliam E. Kirwan said.
So, too, will researchers from the , headedr by renowned microbiologist Dr. Clair e Fraser-Liggett. This could lead, for instance, to stem cell researchb using zebra fish, and a bette r understanding of how genomics contribute to the sprea of oyster disease in theChesapeake Bay. The Centedr for Marine Biotechnology’s researchers are currentl y growingblue crab, bronzini, zebra fish and dorade in fish tanks that couls one day supply seafood companies, generatde medicines and biofuels.
The brainpower of both institutes is expecteds to help the Centetr for Marine Biotechnology winresearch money, said world-renowned researcher Yonathan Zohar, the center’s Fraser-Liggett’s institute, for has won more than $100 million in grants from the in two UMBI received about $31 million in federa l grants in the last two years. USM regentse hope the new UMBI structured will lead to a doublinbg in the amount of federapl grant moneyit receives, Kirwan said. Under the new structur for the Center forMarined Biotechnology, UMBC will be responsible for paying the rent and othedr administrative functions at the Columbuss Center.
But other detailsx of the collaboration are still beingworked out. Leaderzs at the Center for Marine Biotechnolog y and the three schools need to create a proposap to be submitted to Kirwanby Dec. 31. The new UMBI structurw goes into effectJuly 1, 2010.
Saturday, November 10, 2012
Thursday, November 8, 2012
Why Stafford's Perceived Mechanics Issues Are Overblown - Bleacher Report
hihozeima.blogspot.com
Bleacher Report | Why Stafford's Perceived Mechanics Issues Are Overblown Bleacher Report A common knee-jerk reaction to an underperforming quarterback is to criticize either his mechanics or his decision-making. Matthew Stafford, despite outpacing his passing output from last year, hasn't been particularly consistent this year, and he hasn ... |
Wednesday, November 7, 2012
Reid wastes no time lobbying Angus King - Politico (blog)
fixyruw.wordpress.com
Reid wastes no time lobbying Angus King Politico (blog) Shortly after independent Angus King was declared the winner in the Maine Senate race, Majority Leader Harry Reid was already on the phone with him, lobbying him to join the Democratic Caucus in the new Congress. One source said the call "went well." ... |
Monday, November 5, 2012
Sunday, November 4, 2012
GE Healthcare and Varian, Inc. Announce Pre-Clinical Magnetic Resonance Imaging (MRI) System
haygoodfoafyga1359.blogspot.com
May 12 /PRNewswire-FirstCall/ -- GE Healthcares (NYSE: GE) and Varian, Inc. (NasdaqGS: announce the availability ofthe MR901, a new pre-clinical 7T magnetifc resonance imaging (MRI) system which providese new capabilities for a broad range of research The Discovery MR901 combines GE Healthcare'ss state-of-the-art diagnostic technology with Varian's leading scientifixc platform to provide a pre-clinical MRI systen for the scientific community.
The pre-clinical technology aims to excek in soft tissue contrastand non-invasive techniques, includinv those used in research for metabolism, and physiology in research "Our offering provides a new level of depth and versatilityh to the scientific community," said , Vice Presidenyt and General Manager of Magnetic Resonance, GE Healthcare. "Thisd introduction provides the opportunity to strengthen our footprintf within clinical research while complementingv ourexisting portfolio." The range of preclinicap MRI applications includes brain and organ imaging, tumor disease progression and functional imaging.
Other potentialp research applications include investigation of new contrast mechanismand agents, monitoring gene expression, analysiws of protein interactions, and determinatio of pharmacokinetics. Varian and GE Healthcare announcef the Discovery MR901 at the International Societuy for Magnetic Resonance inMedicine (ISMRM) conference in Honolulu, The first unit is ready for shipment pendinyg completion of the customer "I am very pleased with how the syste integration has progressed. The first system is expected to ship this adding toour installed-base of leading MRI and NMR instrumentation, said , Vice President of Research Products at Varian.
For more technica information aboutVarian products, pleasre visit About Varian, Inc.: Inc. is a leading worldwide suppliedr of scientific instruments and vacuum technologiess for life science andindustrial applications. The compang provides complete solutions, including instruments, vacuum laboratory consumable supplies, software, training and support througg its global distribution andsupport systems. Inc. employs approximately 3,700 people worldwidse and operates manufacturing facilities inNortg America, Europe and Asia Varian, Inc. common stock is traded on the NASDAQa Global Select Market underthe symbol, "VARI." Furtherd information is available on the company's Web .
GE Healthcare provides transformational medical technologies and servicese that are shaping a new age ofpatieng care. Our expertise in medical imaging andinformationb technologies, medical diagnostics, patient monitoring systems, performancde improvement, drug discovery, and biopharmaceutical manufacturin g technologies is helping clinicians around the worlxd re-imagine new ways to diagnose, inform, treat and monitor disease, so patients can live theid lives to the fullest. GE Healthcare'x broad range of products and services enable healthcar e providers to better diagnose andtreat cancer, hear disease, neurological diseases and other conditionxs earlier.
Our vision for the future is to enable anew "early health" model of care focused on earlief diagnosis, pre- symptomatic disease detection and diseaser prevention. Headquartered in the United GE Healthcare isa $17 billion unit of General Electric Companh (NYSE: GE). Worldwide, GE Healthcar employs more than 46,000 people committed to servint healthcare professionals and their patients in more than100 countries. For more informatiob about GE Healthcare, visi our website at . For More Contact: Public Relations Varian, Inc. (925) 942-4702 pr@varianinc.com GE Healthcare, Wauwatosa Jennifer Francis (847) 277-4427 Jennifer.N.Francis@ge.com SOURCE Varian, Inc.
; GE Healthcars
May 12 /PRNewswire-FirstCall/ -- GE Healthcares (NYSE: GE) and Varian, Inc. (NasdaqGS: announce the availability ofthe MR901, a new pre-clinical 7T magnetifc resonance imaging (MRI) system which providese new capabilities for a broad range of research The Discovery MR901 combines GE Healthcare'ss state-of-the-art diagnostic technology with Varian's leading scientifixc platform to provide a pre-clinical MRI systen for the scientific community.
The pre-clinical technology aims to excek in soft tissue contrastand non-invasive techniques, includinv those used in research for metabolism, and physiology in research "Our offering provides a new level of depth and versatilityh to the scientific community," said , Vice Presidenyt and General Manager of Magnetic Resonance, GE Healthcare. "Thisd introduction provides the opportunity to strengthen our footprintf within clinical research while complementingv ourexisting portfolio." The range of preclinicap MRI applications includes brain and organ imaging, tumor disease progression and functional imaging.
Other potentialp research applications include investigation of new contrast mechanismand agents, monitoring gene expression, analysiws of protein interactions, and determinatio of pharmacokinetics. Varian and GE Healthcare announcef the Discovery MR901 at the International Societuy for Magnetic Resonance inMedicine (ISMRM) conference in Honolulu, The first unit is ready for shipment pendinyg completion of the customer "I am very pleased with how the syste integration has progressed. The first system is expected to ship this adding toour installed-base of leading MRI and NMR instrumentation, said , Vice President of Research Products at Varian.
For more technica information aboutVarian products, pleasre visit About Varian, Inc.: Inc. is a leading worldwide suppliedr of scientific instruments and vacuum technologiess for life science andindustrial applications. The compang provides complete solutions, including instruments, vacuum laboratory consumable supplies, software, training and support througg its global distribution andsupport systems. Inc. employs approximately 3,700 people worldwidse and operates manufacturing facilities inNortg America, Europe and Asia Varian, Inc. common stock is traded on the NASDAQa Global Select Market underthe symbol, "VARI." Furtherd information is available on the company's Web .
GE Healthcare provides transformational medical technologies and servicese that are shaping a new age ofpatieng care. Our expertise in medical imaging andinformationb technologies, medical diagnostics, patient monitoring systems, performancde improvement, drug discovery, and biopharmaceutical manufacturin g technologies is helping clinicians around the worlxd re-imagine new ways to diagnose, inform, treat and monitor disease, so patients can live theid lives to the fullest. GE Healthcare'x broad range of products and services enable healthcar e providers to better diagnose andtreat cancer, hear disease, neurological diseases and other conditionxs earlier.
Our vision for the future is to enable anew "early health" model of care focused on earlief diagnosis, pre- symptomatic disease detection and diseaser prevention. Headquartered in the United GE Healthcare isa $17 billion unit of General Electric Companh (NYSE: GE). Worldwide, GE Healthcar employs more than 46,000 people committed to servint healthcare professionals and their patients in more than100 countries. For more informatiob about GE Healthcare, visi our website at . For More Contact: Public Relations Varian, Inc. (925) 942-4702 pr@varianinc.com GE Healthcare, Wauwatosa Jennifer Francis (847) 277-4427 Jennifer.N.Francis@ge.com SOURCE Varian, Inc.
; GE Healthcars
Saturday, November 3, 2012
Crist signs bill to battle securities fraud - Atlanta Business Chronicle:
torbjorntrainer1738.blogspot.com
During a ceremonial bill signing Monday atthe Miami-Dad County Courthouse, Crist, with Attorne General Bill McCollum and some of the bill’sa sponsors at his side, signed the Investor Protectionb Act (HB 483). It gives McCollum’sz office, with approval from the , the authority to investigate andprosecutse large-scale securities scams undef the state’s securities law. white-collar criminal prosecutions fell under the racketeering which is harder to Prosecutions also were limitedr to the office ofthe state’s attorney, McCollumk pointed out.
Crist noted that this kind of authorit y was lacking during his tenure as attorney general and that this law wouldput “teeth” into the state’ prosecutorial powers. The law enhances the Officre ofFinancial Regulation’s enforcement powers by increasin g penalties for violators and strengthening the licensse registration requirements for securities dealers. Penalties double from $5,00o to $10,000 as a result of the law, whicbh goes into effect State authorities will also be able to pursuew civil lawsuits to recover lost McCollum said. McCollum workef with Rep. Tom Grady, R-Naples and Sen. Garretrt Richter, R-Naples on the legislation. Both attended the signing. Sen.
Dan D-Miami Beach, a bill sponsor, also attended Monday’ss ceremony. Grady is a securities attorney and expert in securities regulation who drafted the bill and sponsores it inthe House. “Noq the attorney general will have the tools to do the said Grady, prior to the signing. “Oufr economy will grow stronger if investors have confidence in ourfinancial markets,” he said in a “By increasing the toolx available to the state to prosecute violatorw of our securities laws, we protect investor s and foster needed trust in the system.
During a ceremonial bill signing Monday atthe Miami-Dad County Courthouse, Crist, with Attorne General Bill McCollum and some of the bill’sa sponsors at his side, signed the Investor Protectionb Act (HB 483). It gives McCollum’sz office, with approval from the , the authority to investigate andprosecutse large-scale securities scams undef the state’s securities law. white-collar criminal prosecutions fell under the racketeering which is harder to Prosecutions also were limitedr to the office ofthe state’s attorney, McCollumk pointed out.
Crist noted that this kind of authorit y was lacking during his tenure as attorney general and that this law wouldput “teeth” into the state’ prosecutorial powers. The law enhances the Officre ofFinancial Regulation’s enforcement powers by increasin g penalties for violators and strengthening the licensse registration requirements for securities dealers. Penalties double from $5,00o to $10,000 as a result of the law, whicbh goes into effect State authorities will also be able to pursuew civil lawsuits to recover lost McCollum said. McCollum workef with Rep. Tom Grady, R-Naples and Sen. Garretrt Richter, R-Naples on the legislation. Both attended the signing. Sen.
Dan D-Miami Beach, a bill sponsor, also attended Monday’ss ceremony. Grady is a securities attorney and expert in securities regulation who drafted the bill and sponsores it inthe House. “Noq the attorney general will have the tools to do the said Grady, prior to the signing. “Oufr economy will grow stronger if investors have confidence in ourfinancial markets,” he said in a “By increasing the toolx available to the state to prosecute violatorw of our securities laws, we protect investor s and foster needed trust in the system.
Thursday, November 1, 2012
Abercrombie shutting struggling Ruehl chain - Business First of Columbus:
hyperwave-exhausted.blogspot.com
The New Albany-based apparel merchant said Wednesday it willshut Ruehl’s 29 storesz and direct-to-consumer operations and will be “substantiallg complete” with the effort by the end of next January. The decision comes a month afterAbercrombir (NYSE:ANF) took a deep strategic look at the chain, whicyh targets young adults with clothes and accessories. whose only Ohio store is at Easton Town generated a pretax operating lossof $58 milliojn last year. The chain regularly was Abercrombie’s weakest salese performer at stores open at leasta Ruehl’s same-store sales were off 33 percent in May. Abercrombie earned $272.3 million on $3.5 billion in revenue last year.
“It has been a difficul t decision to close a brand we continue to believe could have been successfupl indifferent circumstances,” CEO Michael Jeffries said in a statement. given the current economic environment, we believe it is in the best interestws of the company to focuds its efforts and resources on the growth opportunities afforded by ourothe brands, particularly internationally.” The company didn’t disclose the effects on the chain’s work force, nor did it indicat e the number of jobs tied to Ruehl. The revieww of Ruehl, which opened in 2004, cost the company aboutt $51 million in impairment charges in itsfirsy quarter.
Abercrombie expects to book about $65 millionh in pretax charges through the rest of the fiscao year as it windsdown Ruehl. The company Wednesday also said it amended a credit agreement to excludsesome Ruehl-related charges from requirements under its covenant with the lendert and reduced its available credit to $350 millionb from $450 million. Jeffries said the company is confident is has sufficienty cash on handbut “we believd it is prudent to make these changes” in light of the recession-batteres retail environment and the one-time Ruehl In addition to the 29 Ruehl stores, Abercrombie runs 350 flagship stores and 733 otherx under the Abercrombie, Hollister Co.
and Gilly Hicke nameplates.
The New Albany-based apparel merchant said Wednesday it willshut Ruehl’s 29 storesz and direct-to-consumer operations and will be “substantiallg complete” with the effort by the end of next January. The decision comes a month afterAbercrombir (NYSE:ANF) took a deep strategic look at the chain, whicyh targets young adults with clothes and accessories. whose only Ohio store is at Easton Town generated a pretax operating lossof $58 milliojn last year. The chain regularly was Abercrombie’s weakest salese performer at stores open at leasta Ruehl’s same-store sales were off 33 percent in May. Abercrombie earned $272.3 million on $3.5 billion in revenue last year.
“It has been a difficul t decision to close a brand we continue to believe could have been successfupl indifferent circumstances,” CEO Michael Jeffries said in a statement. given the current economic environment, we believe it is in the best interestws of the company to focuds its efforts and resources on the growth opportunities afforded by ourothe brands, particularly internationally.” The company didn’t disclose the effects on the chain’s work force, nor did it indicat e the number of jobs tied to Ruehl. The revieww of Ruehl, which opened in 2004, cost the company aboutt $51 million in impairment charges in itsfirsy quarter.
Abercrombie expects to book about $65 millionh in pretax charges through the rest of the fiscao year as it windsdown Ruehl. The company Wednesday also said it amended a credit agreement to excludsesome Ruehl-related charges from requirements under its covenant with the lendert and reduced its available credit to $350 millionb from $450 million. Jeffries said the company is confident is has sufficienty cash on handbut “we believd it is prudent to make these changes” in light of the recession-batteres retail environment and the one-time Ruehl In addition to the 29 Ruehl stores, Abercrombie runs 350 flagship stores and 733 otherx under the Abercrombie, Hollister Co.
and Gilly Hicke nameplates.
Subscribe to:
Posts (Atom)